Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last kr2.40 SEK
Change Today -0.22 / -8.40%
Volume 30.3K
As of 12:00 PM 10/8/15 All times are local (Market data is delayed by at least 15 minutes).

idl biotech ab- b shares (IDLB) Snapshot

Previous Close
Day High
Day Low
52 Week High
02/19/15 - kr3.14
52 Week Low
10/10/14 - kr0.82
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IDL BIOTECH AB- B SHARES (IDLB)

Related News

No related news articles were found.

idl biotech ab- b shares (IDLB) Related Businessweek News

No Related Businessweek News Found

idl biotech ab- b shares (IDLB) Details

IDL Biotech AB (publ), a diagnostic company, develops, produces, and markets in vitro diagnostic tests in the areas of oncology and bacteriology worldwide. Its oncology product includes MonoTotal, a tool for the management of patients with non-small cell lung cancer; TPAcyk, a quantitative serum monoclonal immunoassay reactive for the management of patients with epithelial cell carcinomas; TPS, a tumor activity marker used to support prognosis, treatment monitoring, and patient follow-up for various epithelial cancers, such as breast, colorectal, ovarian, and prostate cancers; and UBC, a non-invasive bladder cancer test. The company’s bacteriology product is TUBEX TF, an in vitro diagnostic test for the detection of acute typhoid fever. IDL Biotech AB (publ) distributes its products through a network of business partners primarily in Africa, Asia, Central America, Europe, and North and South America. The company was formerly known as AB IDL ImmunoDevelopLab and changed its name to IDL Biotech AB (publ) in 1998. IDL Biotech AB (publ) was founded in 1988 and is based in Bromma, Sweden.

Founded in 1988

idl biotech ab- b shares (IDLB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

idl biotech ab- b shares (IDLB) Key Developments

IDL Biotech AB (publ) to Report First Half, 2015 Results on Aug 26, 2015

IDL Biotech AB (publ) announced that they will report first half, 2015 results on Aug 26, 2015

IDL Biotech AB (publ), Annual General Meeting, May 20, 2015

IDL Biotech AB (publ), Annual General Meeting, May 20, 2015.

IDL Biotech AB (publ) to Report Q1, 2015 Results on Apr 23, 2015

IDL Biotech AB (publ) announced that they will report Q1, 2015 results on Apr 23, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IDLB:SS kr2.40 SEK -0.22

IDLB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for IDLB.
View Industry Companies

Industry Analysis


Industry Average

Valuation IDLB Industry Range
Price/Earnings 54.1x
Price/Sales 2.6x
Price/Book 13.0x
Price/Cash Flow 31.2x
TEV/Sales 2.5x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IDL BIOTECH AB- B SHARES, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at